The spinal fusion devices market is projected to grow significantly, reaching a value of approximately US$ 12,993.25 million by 2030, up from US$ 8,276.31 million in 2022. This growth represents a compound annual growth rate (CAGR) of 5.8% from 2022 to 2030.
In recent years, there has been a notable increase in spinal fusion surgeries globally, driven by advancements in surgical techniques. Innovations in technology have led to a diverse range of interbody devices, which are increasingly being utilized as alternatives to traditional bone grafting materials. This shift has contributed to a rise in the number of spinal fusion procedures performed. The evolution of spinal fusion methods has also facilitated the use of pedicle screws for posterior instrumentation, further propelling market expansion. Additionally, the introduction of various spinal fusion techniques, including interbody fusion with stand-alone cages and approaches from anterior, lateral, or posterior angles tailored to specific surgical needs and patient conditions, has significantly boosted the volume of spinal fusion surgeries.
As the indications for spinal fusion have expanded, the frequency of these procedures has increased. A study published in Clinical Orthopaedics and Related Research (CORR) by the Association of Bone and Joint Surgeons in February 2023 indicated that the demand for posterior spinal fusion surgeries is expected to rise by 80% by the year 2060. This increase is particularly anticipated among patients aged 75 and older. The study projected that by 2060, there would be 38,974 posterior spinal fusion procedures performed on this age group, a substantial increase from 14,657 in 2019. This surge in procedures is largely attributed to age-related muscle mass decline. Given these projections, the spinal fusion devices market is poised for significant growth during the forecast period and beyond.
Minimally Invasive Spine Surgery Segment Expected to Accelerate Market Growth
Minimally invasive spine surgery (MISS) has gained considerable traction compared to traditional open spine surgery. The smaller incisions required for MISS make it more appealing to patients. The benefits of this approach, such as reduced damage to surrounding muscles, decreased blood loss, less postoperative pain, quicker recovery times, and shorter hospital stays, have led to a higher acceptance of MISS. Currently, MISS is a prevalent method for spinal fusion. The increasing adoption of MISS is particularly evident in treating spinal conditions in older adults and critically ill patients, as it minimizes risks and aligns with changing reimbursement models and patient preferences. Furthermore, advancements in MISS have introduced innovative intraoperative imaging techniques that integrate advanced software, enabling real-time navigation for surgeons and enhancing their understanding of the spine's three-dimensional (3D) anatomy. Consequently, the rapid evolution of MISS is driving the fastest growth within this segment, which in turn propels overall market expansion. According to a July 2022 article titled "Minimally Invasive Spine Surgery Type: An Overview," approximately 75% of the 1.2 million spine procedures performed annually in the United States utilize MISS techniques. Similarly, a January 2022 article, "Spinal Endoscopy: Evidence, Techniques, Global Trends, and Future Projections," reported that 96.7% of surgeons in Asia employ MISS. Therefore, the increasing prevalence of MISS procedures is expected to significantly contribute to market growth in the upcoming years.
Market Segmentation Overview:
The spinal fusion devices market is segmented based on product type, surgical approach, disease indication, and end user.
In terms of product type, the market is divided into thoracolumbar, cervical fixation, and interbody fusion devices. As of 2022, the thoracolumbar segment held the largest market share. The interbody fusion devices segment is anticipated to experience substantial growth during the period from 2022 to 2030, driven by ongoing advancements in interbody fusion technology.
By surgical approach, the spinal fusion devices market is categorized into minimally invasive spine surgery and open spine surgery. In 2022, open spine surgery accounted for the largest market share, while the minimally invasive segment is expected to witness the highest growth rate during the forecast period due to the increasing preference for minimally invasive techniques.
Regarding disease indication, the market is classified into degenerative disc disease, trauma and fractures, complex deformities, and others. The degenerative disc segment held the largest market share in 2022 and is projected to grow at the highest CAGR from 2022 to 2030, primarily due to the rising geriatric population that is more susceptible to degenerative conditions.
Based on end user, the spinal fusion devices market is segmented into hospitals, specialty clinics, and other facilities. In 2022, hospitals represented the largest segment and are expected to continue growing at a rapid pace in the coming years.
Key players in the spinal fusion devices market include DePuy Synthes Inc, Stryker Corp, B. Braun SE, ATEC Spine Inc, Globus Medical Inc, NuVasive Inc, ZimVie Inc, Medtronic Plc, Centinel Spine LLC, and Orthofix Medical Inc.
Important sources referenced in the preparation of this report include the American Association for Thoracic Surgery (AATS), the Food and Drug Administration (FDA), the Ministry of Health, Labor and Welfare (MHLW), the Centers for Disease Control and Prevention (CDC), and the Spanish National Health System (SNS), among others.